Seeking Alpha

Mylan Laboratories (MYL -0.9%) has the opportunity to "create" earnings if a shortfall exists...

Mylan Laboratories (MYL -0.9%) has the opportunity to "create" earnings if a shortfall exists after it bought intellectual knowledge from Pfizer, according to forensic accounting expert Howard Schilit. The key is a $348M contingent consideration liability the company carries for possible milestone payments, royalties, and profit sharing on the deal that can be legally adjusted in any given quarter to reduce expenses for the period.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|